President Obama and Dr. Sanjay Gupta discuss the impact of environmental factors on public health. Climate change affects issues ranging from allergies and asthma to injury and infectious…
AsthmaMD has created an app for iOS and Android that will make asthma control for patients, and asthma tracking for physicians, simpler than ever before. With easy to…
For the past few decades, alpha-1 antitrypsin deficiency (AATD) treatment has been mostly limited to enzyme therapy. While this type of therapy is able to treat symptoms of…
For the past few decades, clinical trials related to alpha-1 antitrypsin deficiency (AATD), have focused on getting more replacement therapy on the market. New areas of AATD research focus…
Bruce Given, MD explains how alpha-1 antitrypsin deficiency (AATD) is most often associated with pulmonary disease in adults and liver disease in children. However, as treatment of adults…
New advancements in the field of alpha-1 antitrypsin research hold promise for the treatment and possible reversal of liver disease. Recent advances in the safety and viability of…
After two unsuccessful attempts to quit smoking, Jodell Kaiser paid a visit to Mayo Clinic and began using Varenicline, a drug that treats nicotine addiction. A study published…
Charlotte Collins, J.D., Senior Vice President, Policy and Programs, Asthma and Allergy Foundation of America, discusses the results from the AAFA Annual Report. According to the report, there…